FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental ANDA for Clozapine from Mylan Pharmaceuticals, approving a generic version of Clozapine under ANDA 201824.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)